Table 3.
Mixed model analyses comparing the differences between the blended acceptance and commitment therapy and cognitive behavioral therapy group over time and between-group effect sizesa.
| Outcome | Unstandardized beta coefficient B | SE | t test (df) | P value | Cohen d | ||||||
| GAD-7b | |||||||||||
|
|
T0-T1 | −3.92 | 0.26 | −15.01 (57) | <.001 | N/Ac | |||||
|
|
T1-T2 | .64 | 0.28 | 2.29 (580) | .02 | N/A | |||||
|
|
T1-T3 | −0.23 | 0.30 | −0.78 (20) | .45 | N/A | |||||
|
|
T0-T1d condition | .18 | 0.52 | 0.35 (57) | .73 | 0.02 | |||||
|
|
T1-T2d condition | −0.63 | 0.56 | −1.13 (580) | .26 | 0.15 | |||||
|
|
T1-T3d condition | −0.33 | 0.60 | −0.54 (20) | .59 | 0.08 | |||||
| MHC-SFe | |||||||||||
|
|
T0-T1 | .29 | 0.05 | 4.55 (34) | <.001 | N/A | |||||
|
|
T1-T2 | .00 | 0.06 | 0.01 (173) | .99 | N/A | |||||
|
|
T1-T3 | −0.06 | 0.06 | −0.90 (71) | .37 | N/A | |||||
|
|
T0-T1d condition | −0.12 | 0.13 | −0.94 (34) | .36 | 0.06 | |||||
|
|
T1-T2d condition | .03 | 0.12 | 0.24 (173) | .82 | 0.03 | |||||
|
|
T1-T3d condition | .27 | 0.13 | 2.13 (71) | .04 | 0.29 | |||||
| PHQ-9f | |||||||||||
|
|
T0-T1 | −3.01 | 0.26 | −11.59 (30) | <.001 | N/A | |||||
|
|
T1-T2 | −0.65 | 0.27 | −2.37 (66) | .02 | N/A | |||||
|
|
T1-T3 | −0.69 | 0.33 | −2.12 (42) | .04 | N/A | |||||
|
|
T0-T1d condition | .31 | 0.52 | 0.59 (30) | .56 | 0.03 | |||||
|
|
T1-T2d condition | −0.67 | 0.55 | −1.21 (66) | .23 | 0.16 | |||||
|
|
T1-T3d condition | −0.53 | 0.66 | −0.80 (42) | .43 | 0.12 | |||||
| SDSg work |
|
||||||||||
|
|
T0-T1 | −1.87 | 0.27 | −6.96 (37) | <.001 | N/A | |||||
|
|
T1-T3 | −.18 | 0.31 | −0.58 (45) | .57 | N/A | |||||
|
|
T0-T1d condition | .28 | 0.54 | 0.53 (37) | .60 | 0.10 | |||||
|
|
T1-T3d condition | .64 | 0.62 | 1.03 (45) | .31 | 0.23 | |||||
| SDS social life | |||||||||||
|
|
T0-T1 | −1.78 | 0.26 | −6.96 (37) | <.001 | N/A | |||||
|
|
T1-T3 | −.15 | 0.27 | −0.55 (27) | .59 | N/A | |||||
|
|
T0-T1d condition | −.18 | 0.51 | −0.35 (37) | .73 | 0.07 | |||||
|
|
T1-T3d condition | 0.08 | 0.55 | 0.15 (27) | .88 | 0.03 | |||||
| SDS family and/or home | |||||||||||
|
|
T0-T1 | −1.93 | 0.22 | −8.78 (44) | <.001 | N/A | |||||
|
|
T1-T3 | −.17 | 0.26 | −0.66 (73) | .51 | N/A | |||||
|
|
T0-T1d condition | .02 | 0.44 | 0.05 (44) | .96 | 0.00 | |||||
|
|
T1-T3d condition | −.38 | 0.51 | −0.74 (73) | .46 | 0.11 | |||||
| CSQ-8h | |||||||||||
|
|
T1 Intercept | 22.83 | 0.35 | 65.20 (34) | <.001 | N/A | |||||
|
|
T1 Condition | 3.19 | 0.70 | 4.58 (37) | <.001 | 0.78 | |||||
| MINI-Plusi (for subgroup without anxiety disorder at baseline)d | |||||||||||
|
|
T1 Intercept | −3.47 | 0.96 | −3.60j | <.001 | N/A | |||||
|
|
T1 Condition | 1.28 | 0.78 | 1.64j | .10 | 3.59 | |||||
|
|
T3 Intercept | −2.38 | 0.47 | −5.09j | <.001 | N/A | |||||
|
|
T3 condition | .05 | 0.70 | 0.07j | .941 | 1.05 | |||||
| MINI-Plus (for subgroup with anxiety disorder at baseline)d | |||||||||||
|
|
T1 intercept | −1.34 | 0.46 | −2.93j | .003 | N/A | |||||
|
|
T1 condition | .38 | 0.62 | 0.61j | .54 | 1.46 | |||||
|
|
T3 intercept | −1.39 | 0.79 | −1.75j | .08 | N/A | |||||
|
|
T3 condition | −1.01 | 1.08 | −0.94j | .35 | 2.75 | |||||
aFor the MINI-Plus and CSQ-8, the condition variable was dummy coded (CBT=0, ACT=1). B is the unstandardized coefficient. T0 stands for baseline; T1 for posttreatment; T2 and T3 for 6- and 12-month follow-up, respectively.
bGAD-7: Generalized Anxiety Disorder-7.
cN/A: not applicable.
dThe presented b-coefficients of logistic mixed model regressions are log-its and effect sizes odds ratios.
eMHC-SF: Mental Health Continuum-Short Form.
fPHQ-9: Patient Health Questionnaire-9.
gSDS: Sheehan Disability Scale.
hCSQ-8: Client Satisfaction Questionnaire-8.
iMINI-Plus: Mini International Neuropsychiatric Interview-Plus.
jReported values are z-values.